Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Mar;29(3):600–604. doi: 10.1128/jcm.29.3.600-604.1991

Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen.

J A Weare 1, E F Robertson 1, G Madsen 1, R Hu 1, R H Decker 1
PMCID: PMC269826  PMID: 2037678

Abstract

Reducing agents dramatically alter the specificity of competitive assays for antibody to hepatitis B core antigen (anti-HBc). A specificity improvement was demonstrated with a new assay which utilizes microparticle membrane capture and chemiluminescence detection as well as a current radioimmunoassay procedure (Corab: Abbott Laboratories, Abbott Park, Ill.). The effect was most noticeable with elevated negative and weakly reactive samples. In both systems, reductants increased separation of a negative population (n = 160) from assay cutoffs. With a selected population (n = 307), inclusion of reductant eliminated apparent anti-HBc activity in 54 of 81 samples in the 30 to 70% inhibition range. Reductant-stable anti-HBc samples were strongly associated with the presence of antibody to hepatitis B surface antigen (21 of 27). The association persisted below the detection limits of current assays to 0.3 to 0.4 Paul Ehrlich Institute units per ml. Only 1 of 54 reduction-sensitive borderline samples was confirmed to be positive for antibody to hepatitis B surface antigen. The modified procedures had unchanged or slightly improved sensitivity for immunoglobulin G (IgG)-associated anti-HBc activity. Although IgM anti-HBc detection was reduced from four- to eightfold in the presence of reductants, sensitivities remained at least twofold greater than tha of an enzyme immunoassay (Corzyme M; Abbott) designed to detect acute-phase levels of IgM anti-HBc. The use of reducing agents should significantly improve the reliability of anti-HBc testing, especially near assay cutoffs.

Full text

PDF
600

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caspari G., Beyer H. J., Elbert G., Koerner K., Muss P., Schunter F. W., Uy A., Gerlich W., Thomssen R., Schmitt H. Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol. 1989 Sep;27(9):2067–2072. doi: 10.1128/jcm.27.9.2067-2072.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chau K. H., Hargie M. P., Decker R. H., Mushahwar I. K., Overby L. R. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc. Hepatology. 1983 Mar-Apr;3(2):142–149. doi: 10.1002/hep.1840030202. [DOI] [PubMed] [Google Scholar]
  3. Hadler S. C., Murphy B. L., Schable C. A., Heyward W. L., Francis D. P., Kane M. A. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol. 1984 Apr;19(4):521–525. doi: 10.1128/jcm.19.4.521-525.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hanson M. R., Polesky H. F. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis. Transfusion. 1987 Jan-Feb;27(1):107–108. doi: 10.1046/j.1537-2995.1987.27187121451.x. [DOI] [PubMed] [Google Scholar]
  5. Koziol D. E., Holland P. V., Alling D. W., Melpolder J. C., Solomon R. E., Purcell R. H., Hudson L. M., Shoup F. J., Krakauer H., Alter H. J. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986 Apr;104(4):488–495. doi: 10.7326/0003-4819-104-4-488. [DOI] [PubMed] [Google Scholar]
  6. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  7. Milich D. R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986 Dec 12;234(4782):1398–1401. doi: 10.1126/science.3491425. [DOI] [PubMed] [Google Scholar]
  8. Schmidt P. J., Leparc G. F., Samia C. T. Comparison of assays for anti-HBc in blood donors. Transfusion. 1988 Jul-Aug;28(4):389–391. doi: 10.1046/j.1537-2995.1988.28488265275.x. [DOI] [PubMed] [Google Scholar]
  9. Stevens C. E., Aach R. D., Hollinger F. B., Mosley J. W., Szmuness W., Kahn R., Werch J., Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med. 1984 Dec;101(6):733–738. doi: 10.7326/0003-4819-101-6-733. [DOI] [PubMed] [Google Scholar]
  10. Sälberg M., Norder H., Weiland O., Magnius L. Immunoglobulin isotypes of anti-HBc and anti-HBe and hepatitis B virus (HBV) DNA elimination in acute hepatitis B. J Med Virol. 1989 Dec;29(4):296–302. doi: 10.1002/jmv.1890290414. [DOI] [PubMed] [Google Scholar]
  11. Sällberg M., Magnius L. O. Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc. J Clin Microbiol. 1989 May;27(5):849–853. doi: 10.1128/jcm.27.5.849-853.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Weeks I., Beheshti I., McCapra F., Campbell A. K., Woodhead J. S. Acridinium esters as high-specific-activity labels in immunoassay. Clin Chem. 1983 Aug;29(8):1474–1479. [PubMed] [Google Scholar]
  13. Wolf-Rogers J., Weare J. A., Rice K., Robertson E. F., Guidinger P., Khalil O. S., Madsen G. A chemiluminescent, microparticle-membrane capture immunoassay for the detection of antibody to hepatitis B core antigen. J Immunol Methods. 1990 Oct 19;133(2):191–198. doi: 10.1016/0022-1759(90)90359-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES